Korro Bio, Inc.

KRRO · Nasdaq · SIC 2834: Pharmaceutical Preparations
132
SEC Filings

Business Summary

PART I Item 1. B usiness. Overview We are a biopharmaceutical company with a mission to discover, develop and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. We are generating a portfolio of differentiated programs that are designed to harness the bodys natural RNA editing process to effect a precise yet transient change to a single nucleoside (adenosine to an inosine edit). By editing RNA instead of DNA, we ...

Next Earnings

Q2 FY2026 — expected 2026-08-16

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionKRROdiscussed_in_filing Cybersecurity
topic_mentionKRROdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-122025-12-310001193125-26-104156EDGAR102K words
2025-03-182024-12-310000950170-25-040759EDGAR—
2024-03-262023-12-310000950170-24-036396EDGAR—
2023-03-102022-12-310000950170-23-007140EDGAR—
2022-03-152021-12-310000950170-22-003655EDGAR—
2021-03-292020-12-310001564590-21-016117EDGAR—
2020-03-262019-12-310001564590-20-012977EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001193125-25-277572EDGAR62K words
2025-08-122025-06-300000950170-25-106912EDGAR—
2025-05-072025-03-310000950170-25-065800EDGAR—
2024-11-122024-09-300000950170-24-125362EDGAR—
2024-08-132024-06-300000950170-24-096189EDGAR—
2024-05-142024-03-310000950170-24-059493EDGAR—
2023-11-022023-09-300000950170-23-058171EDGAR—
2023-08-102023-06-300000950170-23-041300EDGAR—
2023-05-122023-03-310000950170-23-021755EDGAR—
2022-11-082022-09-300000950170-22-023231EDGAR—
2022-08-092022-06-300000950170-22-016072EDGAR—
2022-05-042022-03-310000950170-22-007423EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-120001193125-26-104135EDGAR3K words
2026-03-090001193125-26-097575EDGAR—
2026-01-270001193125-26-023436EDGAR—
2026-01-150001193125-26-014087EDGAR—
2025-12-180001193125-25-324795EDGAR—
2025-11-120001193125-25-277556EDGAR—
2025-10-080001193125-25-234001EDGAR—
2025-08-120000950170-25-106910EDGAR—
2025-06-110000950170-25-084846EDGAR—
2025-05-070000950170-25-065786EDGAR—

132 total filings indexed. 103 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001703647
TickerKRRO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 3b01c8575e01e9b5e4eacda58d79036386f4731a243f7572357d947e7133d28e
parent: 77414aa9c1aea8739ee89fa42ec3644a1c1c818c1bf99eed39b23c205e8b9fcc
content hash: 19a5882449716dfd71d025913a512deec6b228d07a13f860d28b34ea707b5440
signed: 2026-04-13T04:45:56.091Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf